These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21316655)

  • 1. A response to "A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure".
    Proctor DM; Thompson CM; Suh M; Harris MA
    Environ Res; 2011 Apr; 111(3):468-70; discussion 471-2. PubMed ID: 21316655
    [No Abstract]   [Full Text] [Related]  

  • 2. A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure.
    Stern AH
    Environ Res; 2010 Nov; 110(8):798-807. PubMed ID: 20843510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of dose-dependent target tissue absorption for linear and non-linear/threshold approaches in development of a cancer-based oral toxicity factor for hexavalent chromium.
    Haney J
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):194-201. PubMed ID: 25910675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
    Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelia.
    Kopec AK; Thompson CM; Kim S; Forgacs AL; Zacharewski TR
    Toxicol Appl Pharmacol; 2012 Jul; 262(2):124-38. PubMed ID: 22561333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on article "Toxicity and carcinogenicity of chromium compounds in humans" by Costa and Klein.
    Post GB; Stern AH
    Crit Rev Toxicol; 2006 Oct; 36(9):777-8; discussion 779. PubMed ID: 17050084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the evidence regarding the carcinogenicity of hexavalent chromium in drinking water.
    Sedman RM; Beaumont J; McDonald TA; Reynolds S; Krowech G; Howd R
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2006 Apr; 24(1):155-82. PubMed ID: 16690539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin-of-exposure values for hexavalent chromium.
    Thompson CM; Kirman CR; Hays SM; Suh M; Harvey SE; Proctor DM; Rager JE; Haws LC; Harris MA
    J Appl Toxicol; 2018 Mar; 38(3):351-365. PubMed ID: 29064106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a cancer-based chronic inhalation reference value for hexavalent chromium based on a nonlinear-threshold carcinogenic assessment.
    Haney JT; Erraguntla N; Sielken RL; Valdez-Flores C
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):466-80. PubMed ID: 23103602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the U.S. EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium.
    Thompson CM; Haws LC; Harris MA; Gatto NM; Proctor DM
    Toxicol Sci; 2011 Jan; 119(1):20-40. PubMed ID: 20947717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity and carcinogenicity of Cr(VI) in animal models and humans.
    Costa M
    Crit Rev Toxicol; 1997 Sep; 27(5):431-42. PubMed ID: 9347224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic responses in the oral cavity of F344 rats and B6C3F1 mice following exposure to Cr(VI): Implications for risk assessment.
    Thompson CM; Rager JE; Suh M; Ring CL; Proctor DM; Haws LC; Fry RC; Harris MA
    Environ Mol Mutagen; 2016 Dec; 57(9):706-716. PubMed ID: 27859739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.
    Thompson CM; Proctor DM; Suh M; Haws LC; Kirman CR; Harris MA
    Crit Rev Toxicol; 2013 Mar; 43(3):244-74. PubMed ID: 23445218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-erythrocyte chromium as an indicator of exposure to hexavalent chromium: An in vivo evaluation in intravenous administered rat.
    Devoy J; Cosnier F; Bonfanti E; Antoine G; Nunge H; Lambert-Xolin AM; Décret MJ; Douteau L; Lorcin M; Sébillaud S; Grossmann S; Michaux S; Müller S; Viton S; Seidel C; Gaté L
    Toxicol Lett; 2019 Oct; 314():133-141. PubMed ID: 31325633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity.
    De Flora S; Camoirano A; Bagnasco M; Bennicelli C; Corbett GE; Kerger BD
    Carcinogenesis; 1997 Mar; 18(3):531-7. PubMed ID: 9067553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium.
    Thompson CM; Proctor DM; Haws LC; Hébert CD; Grimes SD; Shertzer HG; Kopec AK; Hixon JG; Zacharewski TR; Harris MA
    Toxicol Sci; 2011 Sep; 123(1):58-70. PubMed ID: 21712504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need for improved science in standard setting for hexavalent chromium.
    Proctor DM; Panko JM; Finley BL; Butler WJ; Barnhart RJ
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):99-101. PubMed ID: 10341141
    [No Abstract]   [Full Text] [Related]  

  • 18. Chromium hexavalent compounds.
    Rep Carcinog; 2004; 11():III63-6. PubMed ID: 21089834
    [No Abstract]   [Full Text] [Related]  

  • 19. Consideration of non-linear, non-threshold and threshold approaches for assessing the carcinogenicity of oral exposure to hexavalent chromium.
    Haney J
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):834-52. PubMed ID: 26493004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the carcinogenicity risk assessment of chromium compounds.
    Nurminen M
    Am J Ind Med; 2004 Mar; 45(3):308-9; author reply 310. PubMed ID: 14991859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.